Apyx Medical Inc (APYX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Apyx Medical Inc (APYX) has a cash flow conversion efficiency ratio of -0.315x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.49 Million) by net assets ($11.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see APYX stock market capitalisation for the company's overall valuation and market capitalisation.
Apyx Medical Inc - Cash Flow Conversion Efficiency Trend (1995–2025)
This chart illustrates how Apyx Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Apyx Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Apyx Medical Inc ranked by their cash flow conversion efficiency. Explore APYX operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cheops Technology France SA
PA:MLCHE
|
N/A |
|
Humacyte Inc
NASDAQ:HUMA
|
-8.403x |
|
Aemetis Inc
NASDAQ:AMTX
|
0.039x |
|
UBM Development AG
VI:UBS
|
0.009x |
|
FACT II Acquisition Corp. Class A Ordinary Shares
NASDAQ:FACT
|
-0.001x |
|
Neumora Therapeutics, Inc.
NASDAQ:NMRA
|
-0.353x |
|
Powercell Sweden
ST:PCELL
|
0.015x |
|
Hanla IMS Co. Ltd
KQ:092460
|
-0.023x |
Annual Cash Flow Conversion Efficiency for Apyx Medical Inc (1995–2025)
The table below shows the annual cash flow conversion efficiency of Apyx Medical Inc from 1995 to 2025. View Apyx Medical Inc stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $14.83 Million | $-8.00 Million | -0.539x | +57.15% |
| 2024-12-31 | $14.34 Million | $-18.05 Million | -1.259x | -545.71% |
| 2023-12-31 | $26.92 Million | $-5.25 Million | -0.195x | +63.67% |
| 2022-12-31 | $37.79 Million | $-20.28 Million | -0.537x | -177.36% |
| 2021-12-31 | $54.01 Million | $-10.45 Million | -0.193x | +23.10% |
| 2020-12-31 | $63.86 Million | $-16.07 Million | -0.252x | +2.96% |
| 2019-12-31 | $71.26 Million | $-18.48 Million | -0.259x | -8.30% |
| 2018-12-31 | $87.77 Million | $-21.01 Million | -0.239x | -42.39% |
| 2017-12-31 | $22.03 Million | $-3.70 Million | -0.168x | -55.40% |
| 2016-12-31 | $26.22 Million | $-2.84 Million | -0.108x | +56.24% |
| 2015-12-31 | $23.40 Million | $-5.79 Million | -0.247x | -178.29% |
| 2014-12-31 | $4.69 Million | $-417.00K | -0.089x | +25.28% |
| 2013-12-31 | $21.33 Million | $-2.54 Million | -0.119x | -1749.74% |
| 2012-12-31 | $22.89 Million | $165.00K | 0.007x | -91.60% |
| 2011-12-31 | $22.12 Million | $1.90 Million | 0.086x | +429.82% |
| 2010-12-31 | $21.77 Million | $-566.00K | -0.026x | -459.43% |
| 2009-12-31 | $21.15 Million | $-98.33K | -0.005x | -111.76% |
| 2008-12-31 | $18.79 Million | $742.83K | 0.040x | -67.48% |
| 2007-12-31 | $16.79 Million | $2.04 Million | 0.122x | -42.27% |
| 2006-12-31 | $14.18 Million | $2.99 Million | 0.211x | +1204.09% |
| 2005-12-31 | $9.94 Million | $-189.62K | -0.019x | -108.64% |
| 2004-12-31 | $9.26 Million | $2.04 Million | 0.221x | +297.81% |
| 2003-12-31 | $7.45 Million | $413.52K | 0.056x | +387.04% |
| 2002-12-31 | $6.49 Million | $73.98K | 0.011x | -91.52% |
| 2001-12-31 | $7.00 Million | $940.78K | 0.134x | +30.68% |
| 2000-12-31 | $6.39 Million | $657.50K | 0.103x | +16.53% |
| 1999-12-31 | $6.01 Million | $530.72K | 0.088x | +5950.81% |
| 1998-12-31 | $9.29 Million | $-14.01K | -0.002x | +96.60% |
| 1997-12-31 | $2.22 Million | $-98.79K | -0.044x | -121.09% |
| 1996-12-31 | $2.02 Million | $425.30K | 0.211x | +594.39% |
| 1995-12-31 | $412.30K | $12.50K | 0.030x | -- |
About Apyx Medical Inc
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and … Read more